Named on one round in the feed.
Since 2024-03-20
| Company | Round | Amount | Announced | Role |
|---|---|---|---|---|
Ultrahuman Ultrahuman sells health tracking devices and services, including continuous glucose monitors and performance analytics, primarily for health-conscious consumers. | Series B Published on thinner evidence, 1 source[ HISTORY ]: An earlier round of this company, found through its checked dossier and read from its own announcement like any round. Not news: never sent, and left out of the feed unless you filter by date. | $35M | 2024-03-20 | [ PART ] |